Introduction
Multiple sclerosis (MS) is a chronic T-lymphocyte mediated disease of the central nervous system (CNS) that affects at least 60 in every 100 000 people in the northern United States, Canada, and northern Europe. Autoimmunity against components of the myelin sheath has been proposed as a pathologic mechanism leading to demyelination. 1, 2 The etiology of MS is unknown, but is considered to involve environmental factors, presumably infectious, which would trigger the disease in genetically susceptible individuals.sought to implicate candidate loci influencing the immune function in MS susceptibility, association and more recently linkage have been reproducibly confirmed only for the major histocompatibility complex. [4] [5] [6] [7] [8] Attention has therefore turned to structural genes of myelin, such as myelin basic protein (MBP), as candidates for susceptibility to MS. 9, 10 Variants of the MBP gene could indeed lead to reduced levels of MBP expression in patients, modify the relative proportions of the different MBP isoforms, in particular those produced during active remyelination, or alter the affinity of DNAbinding proteins, and thus contribute to the disease. The MBP transcription unit consists of seven exons distributed over a length of 30 kb 11 and is part of a complex genetic locus called the Golli (for gene expessed in the oligodendrocyte lineage)-MBP on chromosome 18qter. This locus is over 165 kb in length and contains two transcription start sites, one which gives rise to four alternatively spliced MBP mRNAs 12, 13 and another which produces at least three alternatively spliced Golli mRNAs that contain exons from the MBP transcription unit. [14] [15] [16] Both the Golli and MBP families are under independent developmental regulation. The Golli-MBP mRNAs are not confined to the human nervous system but are also expressed within the thymus, spleen, and in cell lines derived from the human immune system. [14] [15] [16] This provides a molecular link between the expression of exons of the MBP gene (and the MBP epitopes they encode) in the central nervous system and in cells and tissues of the immune system and may give some insight into the mechanism whereby MBP-reactive T cells are produced or deleted in an individual. 15 A 1.0 kb region of tandem repetitive sequence has been located from 1082 to 2075 bp upstream from the initiator methionine of the MBP gene. 9 The sequence of this region, which contains 137 non-overlapping repeats of the (TGGA) tetramer, is 45% diverged from the theoretical maximum of 249 repeats and is polymorphic. 9, 17, 18 It is noteworthy that extensive and in some cases superimposed repetition of higher order subsequences has occurred within this region, suggesting that the mutational process that has generated polymorphism has involved not only simple changes in the number of tetranucleotide repeats but also more complex rearrangements. Several groups have used the polymorphism of this region to conduct association, classic linkage and affected sib-pair studies, with conflicting results. [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] However, because of the complexity of the region analysed, homoplasy (ie, alleles of the same size having different internal structures and separate evolutionary histories) cannot be ruled out. Such a phenomenon, which has already been described for other repeated elements in the human genome, 31 would considerably reduce the interest of this marker for linkage disequilibrium studies and might at least partly explain the conflicting results obtained so far for MBP.
To overcome this problem, we have isolated and characterised a new polymorphic microsatellite within the MBP gene and used this simple CA-repeat marker to examine the potential role of MBP alleles in susceptibility to multiple sclerosis.
Results
Isolation of a new microsatellite marker within the MBP gene A (CA) 10 probe hybridised to a 550-bp RsaI fragment of cosmid ICRFc111I0642 that was subcloned into pGEM-3Z Vector (Promega) and sequenced on an ABI 373 DNA Sequencing System. This fragment was shown to contain a microsatellite consisting of 18 repeats of the CA/GT dinucleotide. The sequence flanking the repeat was used to design PCR primers, as indicated on Figure 1 . Amplification of the cosmid DNA by these primers yielded a PCR product of 177 bp. In a sample of 186 chromosomes from healthy unrelated individuals, three alleles were identified, with frequencies of 41.4% (173 bp), 4.3% (175 bp), and 54.3% (177 bp), respectively. The observed number of heterozygotes (48/93 individuals, ie, 51.6%) was compared to its expectation under Hardy-Weinberg equilibrium (53.2%) by a goodness-of-fit chi-square and no significant departure was observed. The MBP alleles segregated in a codominant manner in all three-generation families studied. Both the (CA) 10 probe and a probe specific from exon 5 of the Golli-MBP gene (5′-CCAGGCATTCTTCGGGTC-3′) hybridised to a NotI fragment of about 20 kb, whereas probes specific from exon 1 (5′-CCCCGGAAGGCGAAGCAG-3′), exon 2 (5′-GAGAATTAAATGCCGAGAAGG-3′), exon 3 (5′-GTCC TCTGAGGTTGTCCG-3′), and exon 6 (5′-GGCTGTGCAA CATGTACAAG-3′) did not. It can thus be deduced from the physical map of the Golli-MBP locus [reference 15 and Figure 2 ] that this new microsatellite marker is contained within a region of about 20 kb located downstream of the NotI site mapped 5′ to MBP exon 1/Golli-MBP exon 5. To further refine the location of this microsatellite with respect to the Golli-MBP locus, the restriction fragments of the cosmid clone obtained by single (BamHI, EcoRI, HindIII, NcoI, and NotI) and double (BamHI/EcoRI, BamHI/HindIII, BamHI/NcoI, and EcoRI/NotI) digestions were separated by agarose gel electrophoresis and processed for Southern blot analysis with the labelled (CA) n probe as well as the probe specific from Golli-MBP exon 5. Comparison of the obtained hybridisation patterns with the available restriction map of the myelin basic protein gene 11 allowed us to map this microsatellite to a HindIII/BamHI fragment of 2 kb located approximately 11.5 kb upstream MBP exon 1/Golli-MBP exon 5 ( Figure 2 ).
Transmission-disequilibrium test (TDT)
Among the 242 patients genotyped for the MBP (CA) n repeat, 153 were singletons and 89 belonged to 43 sibships recruited throughout France (Figure 3 ). DNAs from Figure 3 Characteristics of the family dataset. were uninformative because both parents were homozygous. In the remaining 153 families, we were able to follow allelic transmission from 213 heterozygous parents to their affected offspring. The numbers of each allele category transmitted and non-transmitted by these 213 heterozygous parents to their affected children are given in Table 1 . Although the 173-bp allele appears to be slightly more often transmitted than other alleles, the difference is not statistically significant after correction for the number of tests performed. Previous analysis of the same data set 5 indicated a strong deviation of transmission of the HLA-DRB1*1501 allele from random (P Ͻ 10
−9
). In order to determine whether HLA contributed to differences in MBP allele frequencies, the patients were subdivided according to their HLA-DRB1*1501 status and the TDT was computed for both groups separately. As can be seen in Table 2 , no linkage disequilibrium between MS and any MBP marker allele was apparent in either group.
Discussion
We characterised a new polymorphic (CA) n repeat within the Golli-MBP locus, different from the complex (TGGA) n repeat in the 5′ region of the MBP gene. The limited number of alleles identified, despite a 53% heterozygosity rate, makes this new marker suitable for transmission disequilibrium studies. We tested this marker for linkage with MS, using the TDT on a sample of 196 nuclear families in which the genotypes of both parents could be unambiguously defined. Indeed, as pointed out by Curtis and Sham, 32 when one parent is untyped, inclusion of the other parent may lead to a bias in support of preferential transmission for more frequent alleles, especially when the child is homozygous or has the same genotype as the remaining parent. We found no evidence of linkage disequilibrium between MS and any of the three alleles of this marker, even when the patients were subdivided according to their HLA-DRB1*1501 status. The present data thus provide no evidence for a contribution of the MBP gene to multiple sclerosis susceptibility in French patients.
Previous association and/or linkage studies between MBP and MS have been performed either with the full (TGGA) n repeat contained in the 5′ region of the MBP gene 19, 21, 23, 27, 29 or with polymorphic subunits of this repeat, 22, [24] [25] [26] 30 with divergent results. Of note, most of the groups that used the full repeat found an association or linkage between MBP and MS, while the groups that have used short subunits of the full repeat have obtained consistently negative results. Technical problems in the assignment of alleles have been evoked as a possible explanation for these divergent results. Amplification of the full repeat indeed leads to large PCR products with relatively small differences between alleles. However, the authors claim they used conservative criteria for allele determination 27 and obtained reproducible allele sizes in different experiments. 19 Genetic heterogeneity has been evoked as another explanation for the differences reported between the study from Finland and elsewhere. 30 However, it is interesting to note that Tienari et al 33 found an association between MS and an allele of the full repeat element 5′ to the MBP gene but did not detect any association between MS and alleles of the three subunits of this tetranucleotide repeat in the same group of Finnish patients.
In the latter study, Tienari et al 33 screened the MBP coding regions, exon-intron boundaries, as well as 600 bp of the MBP promoter and an enhancer region for polymorphisms, using the index patient of each of their families and unrelated controls, and found only five polymorphisms, none of them predicted to result in an amino acid change. It is thus unlikely that mutations in the MBP coding regions contribute to susceptibility in northern European patients with multiple sclerosis. However, analysis of marker/marker associations between the different polymorphisms demonstrated linkage disequilibrium of the markers located between the MBP enhancer (approximately 4 kb upstream MBP exon 1) and MBP intron 1. This led the authors to subdivide the MS-associated allele of the full repeat element into haplotypes and to identify a MS-predisposing haplotype in their families. Since the (CA) n marker described in this study is only 7 kb upstream the MBP enhancer, it might well be in linkage disequilibrium with some of the biallelic nucleotide polymorphisms identified by Tienari et al 33 and prove useful to better delineate the MS-predisposing haplotype in the Finnish families. This is especially relevant since neither the five biallelic polymorphisms identified recently, 33 nor the subunits contained within the 5′ part of the full repeat, or the new (CA) n repeat reported in this study, have been shown to be independently associated with MS.
The possibility that mutations within the complex (TGGA) n repeat, rather than recombinations, have led to the diversity of the extended haplotypes is compatible with the available data. Some of these mutations could have a direct effect on MS susceptibility, analogous to what has been reported with the type 1 diabetes associated minisatellite 5′ to the insulin gene. 34, 35 Golli-MBP mRNAs are transcribed in the human thymus [14] [15] [16] and it would be interesting to test whether their transcription levels correlate with allelic variation at the complex (TGGA) n repeat. Higher levels of Golli-MBP in the thymus might indeed promote negative selection of MBPspecific T-lymphocytes which play a critical role in the pathogenesis of multiple sclerosis.
Materials and methods
Isolation of the (CA) n repeat Cosmid clone ICRFc111I0642 was isolated from a chromosome 18 library constructed in Lawrist 4 36 by hybridisation with a 708 bp cDNA isolated by Grima et al 14 and corresponding to exons 2, 3, 5a, 5b, and 5c of the Golli-MBP gene. 15 The cosmid was digested with different restriction enzymes and screened for simple repeat sequences with a (CA) 10 oligonucleotide. Transfers and hybridisations were performed with standard techniques. 37 Filters were washed in 2X SSC; 0.1% SDS 30 min at room temperature, and 30 min at 50°C.
PCR conditions and automated product analysis
In each case, 50 ng of genomic DNA were amplified in a total volume of 20 l, using 0.5 U Taq DNA polymerase (Promega) and oligonucleotide primers MBP1 (5′-TTT GAG TGT TCT ATG TTC CC-3′) and MBP2 (5′-TGG ACG GTA AGC TGG AAA C-3′). Each reaction contained 10 mm Tris-HCl pH 9, 50 mm KCl, 1.5 mm MgCl 2 , 0.2 mm each dNTP, and 0.5 m each primer. Oligonucleotide MBP1 was labelled with the fluorescent dye '6-FAM' (Applied Biosystems). PCR was carried out in a GeneAmp PCR System 9600 (Perkin Elmer). Samples were initially denatured at 94°for 1 min 30 s, before undergoing 25 cycles of 94°for 30 s, 52°for 30 s, and 72°for 30 s. Amplification products were loaded onto 6% denaturing polyacrylamide gels with an internal lane standard labelled with the 'ROX' dye (Perkin Elmer), and analysed on an ABI 373 DNA Sequencing System. Sizing of the products was performed automatically by 672 Genescan Analysis software using the Southern Local method to establish a curve of best fit through the fragments of the internal standard in each lane.
DNA samples
The degree of polymorphism of the (CA) n repeat was assessed in a sample of 186 chromosomes from 93 healthy unrelated individuals of French ancestry, and the segregation of the different alleles explored in five three-generation families (46 meiotic events) of similar origin. The length variability of this repeat was then ascertained in 196 MS nuclear families (153 simplex and 43 multiplex). The 153 patients belonging to the simplex families fulfilled the criteria for definite MS according to Poser et al 38 and the 89 patients from multiplex families the Goodkin et al 39 criteria for research protocols in familial MS. Of the 242 patients, 239 were genotyped by PCR oligotyping 40 for the HLA marker DRB1.
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Statistical analysis
We assumed that, would the MBP gene contribute to MS susceptibility, an association should be found between MS and the newly described marker localised within the MBP locus. We thus used the transmission-disequilibrium test (TDT) of Spielman et al 41 to test for linkage between MS and this (CA) n repeat. The TDT indeed was shown to have greater power than nonparametric affected-sib-pair methods for candidate genes that make only a modest contribution to a disease. 42 In the TDT, transmission of a particular allele from heterozygous parents to their affected offspring is examined. Under Mendelian inheritance, ie, when the marker and disease are unlinked, all alleles should have a 50% chance of being transmitted to the next generation. In contrast, if there is linkage and one of the alleles is associated with disease risk, it will be transmitted more often than 50% of the time. The transmission data from families with either single affected individuals or with multiple affected siblings and their parents can be combined, and the TDT is applied to each affected individual separately. The deviation from the null hypothesis of 50% transmission from heterozygous parents is tested by the exact binomial test and multiple testing is taken into account by application of a Bonferroni correction.
